India Pharma Outlook Team | Saturday, 06 July 2024
Pulsus Group intends to establish an AI-based pharma healthcare IT cluster in Ameenpur, Sangareddy district, Telangana, at a cost of Rs 300 crore with the potential to create approximately 50,000 jobs.
Pulsus Group CEO and managing director Dr Srinubabu Gedela announced this on the first day of the 73rd Indian Pharmaceutical Congress here on Friday, stating that the project will catalyze the healthcare and IT landscape, creating an estimated 10,000 direct jobs and approximately 40,000 indirect jobs through supporting industries and services.
The initiative, which will be based in Ameenpur's IT/ITeS zone, will use AI technologies to enrich all elements of pharmaceuticals, from research and development to healthcare delivery, while also creating a substantial number of jobs for inhabitants, according to him.
“By integrating the most advanced artificial intelligence, we aim to streamline processes, enhance precision in drug development, and improve patient outcomes. This positions Telangana at the forefront of healthcare innovation in India," Gedela said.
Addressing the summit, Telangana Industries and IT Minister D Sridhar Babu stated that the pharmaceutical industry's adoption of AI and other cutting-edge technology will help make pharmaceuticals and treatments more affordable for consumers.
Telangana Chief Minister A Revanth Reddy has decided to take a cluster-based and decentralised development approach, with 9-10 pharma zones across the state, to ensure a self-sustaining ecosystem and generate employment in rural areas, he said.